Works matching IS 08876924 AND DT 2013 AND VI 27 AND IP 8

Results: 35

Personalized management of essential thrombocythemia-application of recent evidence to clinical practice.

Published in:

2013

By:

Tefferi, A;
Barbui, T

Publication type:

journal article

MAGE-C1/CT7 spontaneously triggers a CD4(+) T-cell response in multiple myeloma patients.

Published in:

2013

By:

Nuber, N;
Curioni-Fontecedro, A;
Dannenmann, S R;
Matter, C;
von Boehmer, L;
Atanackovic, D;
Knuth, A;
van den Broek, M

Publication type:

Journal Article

Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.

Published in:

2013

By:

Storti, P;
Bolzoni, M;
Donofrio, G;
Airoldi, I;
Guasco, D;
Toscani, D;
Martella, E;
Lazzaretti, M;
Mancini, C;
Agnelli, L;
Patrene, K;
Maïga, S;
Franceschi, V;
Colla, S;
Anderson, J;
Neri, A;
Amiot, M;
Aversa, F;
David Roodman, G;
Giuliani, N

Publication type:

journal article

Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1786, doi. 10.1038/leu.2013.57

By:

Aalbers, A M;
Calado, R T;
Young, N S;
Zwaan, C M;
Wu, C;
Kajigaya, S;
Coenen, E A;
Baruchel, A;
Geleijns, K;
de Haas, V;
Kaspers, G J L;
Kuijpers, T W;
Reinhardt, D;
Trka, J;
Zimmermann, M;
Pieters, R;
van der Velden, V H J;
van den Heuvel-Eibrink, M M

Publication type:

Article

Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1715, doi. 10.1038/leu.2013.50

By:

Scullen, T;
Santo, L;
Vallet, S;
Fulciniti, M;
Eda, H;
Cirstea, D;
Patel, K;
Nemani, N;
Yee, A;
Mahindra, A;
Raje, N

Publication type:

Article

Gads (Grb2-related adaptor downstream of Shc) is required for BCR-ABL-mediated lymphoid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1666, doi. 10.1038/leu.2013.40

By:

Gillis, L C;
Berry, D M;
Minden, M D;
McGlade, C J;
Barber, D L

Publication type:

Article

Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1677, doi. 10.1038/leu.2013.28

By:

Locatelli, S L;
Giacomini, A;
Guidetti, A;
Cleris, L;
Mortarini, R;
Anichini, A;
Gianni, A M;
Carlo-Stella, C

Publication type:

Article

Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1707, doi. 10.1038/leu.2013.29

By:

Badros, A Z;
Vij, R;
Martin, T;
Zonder, J A;
Kunkel, L;
Wang, Z;
Lee, S;
Wong, A F;
Niesvizky, R

Publication type:

Article

Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1697, doi. 10.1038/leu.2013.24

By:

Storti, P;
Bolzoni, M;
Donofrio, G;
Airoldi, I;
Guasco, D;
Toscani, D;
Martella, E;
Lazzaretti, M;
Mancini, C;
Agnelli, L;
Patrene, K;
Maïga, S;
Franceschi, V;
Colla, S;
Anderson, J;
Neri, A;
Amiot, M;
Aversa, F;
David Roodman, G;
Giuliani, N

Publication type:

Article

The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1729, doi. 10.1038/leu.2013.76

By:

Kocemba, K A;
van Andel, H;
de Haan-Kramer, A;
Mahtouk, K;
Versteeg, R;
Kersten, M J;
Spaargaren, M;
Pals, S T

Publication type:

Article

Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1760, doi. 10.1038/leu.2013.20

By:

Yip, B H;
Vuppusetty, C;
Attwood, M;
Giagounidis, A;
Germing, U;
Lamikanra, A A;
Roberts, D J;
Maciejewski, J P;
Vandenberghe, P;
Mecucci, C;
Wainscoat, J S;
Pellagatti, A;
Boultwood, J

Publication type:

Article

A novel therapeutic molecule against HTLV-1 infection targeting provirus.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1621, doi. 10.1038/leu.2013.46

By:

Tanaka, A;
Takeda, S;
Kariya, R;
Matsuda, K;
Urano, E;
Okada, S;
Komano, J

Publication type:

Article

Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1637, doi. 10.1038/leu.2013.75

By:

Saito, Y;
Kaneda, K;
Suekane, A;
Ichihara, E;
Nakahata, S;
Yamakawa, N;
Nagai, K;
Mizuno, N;
Kogawa, K;
Miura, I;
Itoh, H;
Morishita, K

Publication type:

Article

Personalized management of essential thrombocythemia-application of recent evidence to clinical practice.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1617, doi. 10.1038/leu.2013.99

By:

Tefferi, A;
Barbui, T

Publication type:

Article

Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1751, doi. 10.1038/leu.2013.4

By:

Kreck, B;
Richter, J;
Ammerpohl, O;
Barann, M;
Esser, D;
Petersen, B S;
Vater, I;
Murga Penas, E M;
Bormann Chung, C A;
Seisenberger, S;
Lee Boyd, V;
Smallwood, S;
Drexler, H G;
MacLeod, R A F;
Hummel, M;
Krueger, F;
Häsler, R;
Schreiber, S;
Rosenstiel, P;
Franke, A

Publication type:

Article

JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1763, doi. 10.1038/leu.2013.21

By:

Wang, J;
Xu, Z;
Liu, L;
Gale, R P;
Cross, N C P;
Jones, A V;
Qin, T;
Ai, X;
Xu, J;
Zhang, T;
Sun, X;
Li, Q;
Zhang, P;
Zhang, Y;
Xiao, Z

Publication type:

Article

Natural history of acute lymphoblastic leukemia in neurofibromatosis type 1 monozygotic twins.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1778, doi. 10.1038/leu.2013.55

By:

Galbiati, M;
Lettieri, A;
Micalizzi, C;
Songia, S;
Morerio, C;
Biondi, A;
Dufour, C;
Cazzaniga, G

Publication type:

Article

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1738, doi. 10.1038/leu.2013.86

By:

Rajkumar, S V;
Gupta, V;
Fonseca, R;
Dispenzieri, A;
Gonsalves, W I;
Larson, D;
Ketterling, R P;
Lust, J A;
Kyle, R A;
Kumar, S K

Publication type:

Article

MAGE-C1/CT7 spontaneously triggers a CD4<sup>+</sup> T-cell response in multiple myeloma patients.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1767, doi. 10.1038/leu.2013.31

By:

Nuber, N;
Curioni-Fontecedro, A;
Dannenmann, S R;
Matter, C;
von Boehmer, L;
Atanackovic, D;
Knuth, A;
van den Broek, M

Publication type:

Article

Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1792, doi. 10.1038/leu.2013.113

By:

Bomken, S;
Buechler, L;
Rehe, K;
Ponthan, F;
Elder, A;
Blair, H;
Bacon, C M;
Vormoor, J;
Heidenreich, O

Publication type:

Article

A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1754, doi. 10.1038/leu.2013.12

By:

Kaiser, M F;
Walker, B A;
Hockley, S L;
Begum, D B;
Wardell, C P;
Gonzalez, D;
Ross, F M;
Davies, F E;
Morgan, G J

Publication type:

Article

Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1782, doi. 10.1038/leu.2013.56

By:

Leanza, L;
Trentin, L;
Becker, K A;
Frezzato, F;
Zoratti, M;
Semenzato, G;
Gulbins, E;
Szabo, I

Publication type:

Article

Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability?

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1777, doi. 10.1038/leu.2013.48

By:

Zebisch, A;
Hoefler, G;
Quehenberger, F;
Wölfler, A;
Sill, H

Publication type:

Article

Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1628, doi. 10.1038/leu.2013.38

By:

DeAngelo, D J;
Spencer, A;
Bhalla, K N;
Prince, H M;
Fischer, T;
Kindler, T;
Giles, F J;
Scott, J W;
Parker, K;
Liu, A;
Woo, M;
Atadja, P;
Mishra, K K;
Ottmann, O G

Publication type:

Article

Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1792, doi. 10.1038/leu.2013.134

By:

Kato, H;
Yamamoto, K;
Oki, Y;
Ine, S;
Taji, H;
Chihara, D;
Kagami, Y;
Seto, M;
Morishima, Y

Publication type:

Article

Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1748, doi. 10.1038/leu.2013.3

By:

Miguet, L;
Lennon, S;
Baseggio, L;
Traverse-Glehen, A;
Berger, F;
Perrusson, N;
Chenard, M-P;
Galoisy, A-C;
Eischen, A;
Mayeur-Rousse, C;
Maar, A;
Fornecker, L;
Herbrecht, R;
Felman, P;
Van Dorsselaer, A;
Carapito, C;
Cianférani, S;
Mauvieux, L

Publication type:

Article

Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1688, doi. 10.1038/leu.2013.41

By:

Tan, S-Y;
Chuang, S-S;
Tang, T;
Tan, L;
Ko, Y-H;
Chuah, K-L;
Ng, S-B;
Chng, W-J;
Gatter, K;
Loong, F;
Liu, Y-H;
Hosking, P;
Cheah, P-L;
Teh, B-T;
Tay, K;
Koh, M;
Lim, S-T

Publication type:

Article

Recurrent involvement of ring-type zinc finger genes in complex molecular rearrangements in childhood acute myelogeneous leukemia with translocation t(10;11)(p12;q23).

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1745, doi. 10.1038/leu.2013.1

By:

Ghosh, S;
Bartenhagen, C;
Okpanyi, V;
Gombert, M;
Binder, V;
Teigler-Schlegel, A;
Bradtke, J;
Röttgers, S;
Dugas, M;
Borkhardt, A

Publication type:

Article

Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1659, doi. 10.1038/leu.2013.52

By:

Logan, A C;
Zhang, B;
Narasimhan, B;
Carlton, V;
Zheng, J;
Moorhead, M;
Krampf, M R;
Jones, C D;
Waqar, A N;
Faham, M;
Zehnder, J L;
Miklos, D B

Publication type:

Article

Cleavage of BCR-ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR-ABL leukemic cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1650, doi. 10.1038/leu.2013.60

By:

Kim, J E;
Yoon, S;
Choi, B-R;
Kim, K P;
Cho, Y-H;
Jung, W;
Kim, D-W;
Oh, S;
Kim, D-E

Publication type:

Article

From in vitro to in vivo: intracellular determination of imatinib and nilotinib may be related with clinical outcome.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1757, doi. 10.1038/leu.2013.13

By:

Bouchet, S;
Dulucq, S;
Pasquet, J-M;
Lagarde, V;
Molimard, M;
Mahon, F-X

Publication type:

Article

Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1769, doi. 10.1038/leu.2013.37

By:

Herman, S E M;
Barr, P M;
McAuley, E M;
Liu, D;
Wiestner, A;
Friedberg, J W

Publication type:

Article

Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: produces stable disease but at the cost of high toxicity.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1789, doi. 10.1038/leu.2013.61

By:

Warlick, E D;
Cao, Q;
Miller, J

Publication type:

Article

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1722, doi. 10.1038/leu.2013.62

By:

Jiménez, C;
Sebastián, E;
Chillón, M C;
Giraldo, P;
Mariano Hernández, J;
Escalante, F;
González-López, T J;
Aguilera, C;
de Coca, A G;
Murillo, I;
Alcoceba, M;
Balanzategui, A;
Sarasquete, M E;
Corral, R;
Marín, L A;
Paiva, B;
Ocio, E M;
Gutiérrez, N C;
González, M;
San Miguel, J F

Publication type:

Article

Stromal cell-induced miRNA alteration in chronic lymphocytic leukemia: how a minute and unavoidable cell contamination impairs miRNA profiling.

Published in:

Leukemia (08876924), 2013, v. 27, n. 8, p. 1773, doi. 10.1038/leu.2013.43

By:

Paggetti, J;
Berchem, G;
Moussay, E

Publication type:

Article